MedTrace Logo

Cancer Genetics Hereditary Cancer Panel Testing

NCT02324062 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1511

Last updated 2026-02-18

No results posted yet for this study

Summary

This study is about understanding the use of a genetic test (Myriad Genetics myRisk panel) that analyzes 25 genes related to different hereditary cancer conditions. The investigators hope to learn more about how this type of genetic test is used clinically. The investigators also hope to understand more about the experience of individuals and families who undergoing this test of genetic testing.

Conditions

  • Hereditary Breast and Ovarian Cancer

Interventions

OTHER

Questionnaires

These participants will be asked to complete questionnaires for the duration of the study (up to 60 months after enrollment) at 3 months, 6 months, 12 months, 24 months, 36 months, 48 months, and 60 months.

OTHER

Blood Draw and Baseline Questionnaire

Participants will have their blood drawn for the study and complete a baseline questionnaire about their current cancer screening practices and concern regarding cancer.

Sponsors & Collaborators

Principal Investigators

  • Gregory Idos, MD · Assistant Professor

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-12
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02324062 on ClinicalTrials.gov